New Classifications of Five Distinct “Sleep” Profi... ...
A Professional Overview of Hypertension ...
High-speed imaging tracks live brain cell activity...
Drug candidate slows motor neuron disease progress...
Drug candidate slows motor neuron disease progress...
Mark Cuban: A Master Disrupter for American Health...
Superbugs on your plate: How antimicrobial resistance spread...
June 13,2026
Can marijuana cause lung cancer?...
June 12,2026
Standard depression screening could be missing key symptoms ...
June 11,2026
More women are having babies later in life. How to improve y...
June 10,2026
For severe babesiosis, red blood cell exchange is associated...
June 09,2026
Cause or effect? Study answers question about gene linked wi...
June 08,2026
Category
Traditional Medicine
Q & A
Wellness
Drug Discovery
Technology & AI
Clinical Pearl Series
Breakthroughs
Immunology & Rheumatology
Reproduction
Hepatobiliary&Pancreas Surgery
Most Read
Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and SexAverage Ranges Show Normal Pressure On the ArteriesBySheryl Huggins SalomonUpdated on April 21, 2023Medically reviewed byJeffre
Cardiovascular Diseases April 07,2024
Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and SexAverage Ranges Show Normal Pressure On the ArteriesBySheryl Huggins SalomonUpdated on April 21, 2023Medically reviewed byJeffre
Cardiovascular Diseases April 07,2024
Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals has commenced dosing the first patients in its Phase 2a clinical trial for PP405, a novel topical treatment designed to reactivate dormant hair follicle stem cells.
Dermatology August 14,2024
Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals has commenced dosing the first patients in its Phase 2a clinical trial for PP405, a novel topical treatment designed to reactivate dormant hair follicle stem cells.
Dermatology August 14,2024
Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs MeanWhat to Know About Your Blood TypeByNancy LeBrunPublished on September 15, 2023Medically reviewed byAnju Goel, MDYou
Oncology March 17,2024
Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs MeanWhat to Know About Your Blood TypeByNancy LeBrunPublished on September 15, 2023Medically reviewed byAnju Goel, MDYou
Oncology March 17,2024
Today's News
Eye Infections (Updated) | Clinical Medicine...
Announcement of the 2025 Nobel Prize in ...
Dr. Fauci among hundreds who've contract...
Why are young, healthy adults experienci...
Reprogramming Stem Cells Could Cure Type...
More News
Clinical trial shows efficacy for atezolizumab combined with carboplatin

Clinical trial shows efficacy for atezolizumab combined with carboplatin

byVanderbilt University Medical CenterCredit: CC0 Public DomainImmunotherapy in combination with chemotherapy has become an important therapeutic treatment option in some patients with metastati
Oncology January 26,2024
Clinical trial shows efficacy for atezolizumab combined with carboplatin

Clinical trial shows efficacy for atezolizumab combined with carboplatin

byVanderbilt University Medical CenterCredit: CC0 Public DomainImmunotherapy in combination with chemotherapy has become an important therapeutic treatment option in some patients with metastati
Oncology January 26,2024
Immunotherapy in first-line standard therapy significantly improves survival in metastatic or recurrent cervical cancer

Immunotherapy in first-line standard therapy significantly improves survival in metastatic or recurrent cervical cancer

byVall d'Hebron Institute of OncologyCredit: CC0 Public DomainPublished inThe Lancet, results of the randomized phase III BEATcc academic trial (ENGOT-Cx10/GEICO 68-C/JGOG1084/GOG-3030
Oncology January 26,2024
Immunotherapy in first-line standard therapy significantly improves survival in metastatic or recurrent cervical cancer

Immunotherapy in first-line standard therapy significantly improves survival in metastatic or recurrent cervical cancer

byVall d'Hebron Institute of OncologyCredit: CC0 Public DomainPublished inThe Lancet, results of the randomized phase III BEATcc academic trial (ENGOT-Cx10/GEICO 68-C/JGOG1084/GOG-3030
Oncology January 26,2024
How the immune system fights to keep herpes at bay

How the immune system fights to keep herpes at bay

by Jake Miller,Harvard Medical SchoolThese microscope images show how interferon in the nucleus raises levels of the protective protein IFI16 (stained green) from low background levels (left) to
Public Health & Prevention January 26,2024
How the immune system fights to keep herpes at bay

How the immune system fights to keep herpes at bay

by Jake Miller,Harvard Medical SchoolThese microscope images show how interferon in the nucleus raises levels of the protective protein IFI16 (stained green) from low background levels (left) to
Public Health & Prevention January 26,2024
Minimizing immunotherapy's potentially harmful side effects

Minimizing immunotherapy's potentially harmful side effects

byUniversity of Miami Leonard M. Miller School of MedicineCredit: Pixabay/CC0 Public DomainRecent advances in treating multiple myeloma, the second most common blood cancer, and other blood mali
Oncology January 25,2024
Minimizing immunotherapy's potentially harmful side effects

Minimizing immunotherapy's potentially harmful side effects

byUniversity of Miami Leonard M. Miller School of MedicineCredit: Pixabay/CC0 Public DomainRecent advances in treating multiple myeloma, the second most common blood cancer, and other blood mali
Oncology January 25,2024
This gross mixture has big benefits for the study of bacteria

This gross mixture has big benefits for the study of bacteria

byUniversity of MichiganDetermining the bottleneck of infection forP. mirabilisduring UTI. (A–C) CBA/J mice were transurethrally inoculated with 107CFU. The inoculum contained
Immunology & Rheumatology January 25,2024
This gross mixture has big benefits for the study of bacteria

This gross mixture has big benefits for the study of bacteria

byUniversity of MichiganDetermining the bottleneck of infection forP. mirabilisduring UTI. (A–C) CBA/J mice were transurethrally inoculated with 107CFU. The inoculum contained
Immunology & Rheumatology January 25,2024
Hope for autoimmune skin disorder sufferers with new immunotherapy strategy

Hope for autoimmune skin disorder sufferers with new immunotherapy strategy

byThe Peter Doherty Institute for Infection and ImmunityCredit: Estzer Miller on PixabayBreakthrough research has revealed new ways to remove immune cells that cause skin autoimmune diseases wit
Immunology & Rheumatology January 25,2024
Hope for autoimmune skin disorder sufferers with new immunotherapy strategy

Hope for autoimmune skin disorder sufferers with new immunotherapy strategy

byThe Peter Doherty Institute for Infection and ImmunityCredit: Estzer Miller on PixabayBreakthrough research has revealed new ways to remove immune cells that cause skin autoimmune diseases wit
Immunology & Rheumatology January 25,2024
Identifying new potential in cancer-killing T cells

Identifying new potential in cancer-killing T cells

by Kate Ledger,Mayo ClinicGraphical illustration of a general role of ME1 in resilient CD8+T cells. Credit:Science Advances(2023). DOI: 10.1126/sciadv.adi2414When Joanina Gicob
Oncology January 25,2024
Identifying new potential in cancer-killing T cells

Identifying new potential in cancer-killing T cells

by Kate Ledger,Mayo ClinicGraphical illustration of a general role of ME1 in resilient CD8+T cells. Credit:Science Advances(2023). DOI: 10.1126/sciadv.adi2414When Joanina Gicob
Oncology January 25,2024
Collaborative study shows CAR-T cell therapy safe, effective even for high-risk patients

Collaborative study shows CAR-T cell therapy safe, effective even for high-risk patients

byUniversity of Miami Leonard M. Miller School of MedicineCredit: Pixabay/CC0 Public DomainCAR-T cell therapy is a safe and effective treatment for diffuse large B-cell lymphoma (DLBCL), even fo
Oncology January 25,2024
Collaborative study shows CAR-T cell therapy safe, effective even for high-risk patients

Collaborative study shows CAR-T cell therapy safe, effective even for high-risk patients

byUniversity of Miami Leonard M. Miller School of MedicineCredit: Pixabay/CC0 Public DomainCAR-T cell therapy is a safe and effective treatment for diffuse large B-cell lymphoma (DLBCL), even fo
Oncology January 25,2024
Researchers show that an influx of water and salts propel immune cells through the body

Researchers show that an influx of water and salts propel immune cells through the body

byThe Francis Crick InstituteCredit: Pixabay/CC0 Public DomainResearchers at the Francis Crick Institute, working with Imperial College London, King's College London and University of Cambri
Immunology & Rheumatology January 25,2024
Researchers show that an influx of water and salts propel immune cells through the body

Researchers show that an influx of water and salts propel immune cells through the body

byThe Francis Crick InstituteCredit: Pixabay/CC0 Public DomainResearchers at the Francis Crick Institute, working with Imperial College London, King's College London and University of Cambri
Immunology & Rheumatology January 25,2024
As dengue expands beyond the global 'dengue belt,' scientists dispel conventional wisdom about the disease

As dengue expands beyond the global 'dengue belt,' scientists dispel conventional wisdom about the disease

by Delthia Ricks , Medical XpressCredit: Pixabay/CC0 Public DomainUnknowns, dangers and surprises persist about dengue viral infection and now an assumption once accepted as conventional wisdom about
Public Health & Prevention January 25,2024
As dengue expands beyond the global 'dengue belt,' scientists dispel conventional wisdom about the disease

As dengue expands beyond the global 'dengue belt,' scientists dispel conventional wisdom about the disease

by Delthia Ricks , Medical XpressCredit: Pixabay/CC0 Public DomainUnknowns, dangers and surprises persist about dengue viral infection and now an assumption once accepted as conventional wisdom about
Public Health & Prevention January 25,2024
More News
Week’s Top
Podcasts
... Preparing for a tough exam? A tough gym workout could help with your studies ... ... GOSH BRC Showcase 2025 - Genomic medicine ... ... Brain activity goes to extremes in soccer fans, neuroimaging reveals ...
FIND US ON
ABOUT
Who We Are
Contact Us
Editorial Team
Sitemap
Policy
Privacy Policy
Advertising Policy
Editorial Policy
Corrections Policy
Medical Disclaimer
Alliance
wmo.com
sleep.net
pharm.net
doctors.net
worldsleep.com